NO964075L - Immunoterapeutisk middel samt anvendelse derav - Google Patents

Immunoterapeutisk middel samt anvendelse derav

Info

Publication number
NO964075L
NO964075L NO964075A NO964075A NO964075L NO 964075 L NO964075 L NO 964075L NO 964075 A NO964075 A NO 964075A NO 964075 A NO964075 A NO 964075A NO 964075 L NO964075 L NO 964075L
Authority
NO
Norway
Prior art keywords
immunotherapeutic agent
immunotherapeutic
agent
Prior art date
Application number
NO964075A
Other languages
English (en)
Norwegian (no)
Other versions
NO964075D0 (no
Inventor
Graham Arthur William Rook
John Lawson Stanford
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of NO964075D0 publication Critical patent/NO964075D0/no
Publication of NO964075L publication Critical patent/NO964075L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO964075A 1994-03-30 1996-09-27 Immunoterapeutisk middel samt anvendelse derav NO964075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406301A GB9406301D0 (en) 1994-03-30 1994-03-30 Immunotherapeutic agent and its use
PCT/GB1995/000715 WO1995026742A1 (fr) 1994-03-30 1995-03-29 Agent d'immunotherapie et son utilisation

Publications (2)

Publication Number Publication Date
NO964075D0 NO964075D0 (no) 1996-09-27
NO964075L true NO964075L (no) 1996-11-25

Family

ID=10752750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964075A NO964075L (no) 1994-03-30 1996-09-27 Immunoterapeutisk middel samt anvendelse derav

Country Status (22)

Country Link
EP (1) EP0752870B1 (fr)
JP (1) JP4135190B2 (fr)
KR (1) KR100392582B1 (fr)
CN (1) CN1121874C (fr)
AP (1) AP9600861A0 (fr)
AT (1) ATE218355T1 (fr)
AU (1) AU699081B2 (fr)
BR (1) BR9507338A (fr)
CA (1) CA2186851C (fr)
CZ (1) CZ280196A3 (fr)
DE (1) DE69526935T2 (fr)
DK (1) DK0752870T3 (fr)
ES (1) ES2177638T3 (fr)
FI (1) FI111223B (fr)
GB (1) GB9406301D0 (fr)
HU (1) HU220858B1 (fr)
NO (1) NO964075L (fr)
NZ (1) NZ282863A (fr)
PT (1) PT752870E (fr)
RU (1) RU2139728C1 (fr)
WO (1) WO1995026742A1 (fr)
ZA (1) ZA952644B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
AU730548B2 (en) * 1996-12-18 2001-03-08 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the TH2 activity of the immune system
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
WO2003063896A1 (fr) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Procede de preparation d'une composition pharmaceutique pour conferer l'immunite contre la tuberculose a des individus hiv-positifs
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
NZ581806A (en) * 2004-06-07 2011-10-28 Qu Biolog Inc Bacterial compositions for the treatment of cancer
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
BG66067B1 (bg) * 2005-05-18 2011-01-31 Спартак ХАДЖИЕВ Средство с антитуморна активност на база бцж ваксина, метод за неговото получаване и използването му
US8557257B2 (en) 2006-03-24 2013-10-15 Oncovac Inc. Mycobacterial immunotherapy for cancer treatment
EP3235506B1 (fr) 2010-07-26 2023-12-06 Qu Biologics Inc. Compositions immunogènes anti-inflammatoires
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
EP3319635B1 (fr) * 2015-06-24 2021-04-21 Immodulon Therapeutics Limited Inhibiteur de point de vérification et mycobactérie à germes entiers destinés à une utilisation dans le traitement de cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions

Also Published As

Publication number Publication date
ATE218355T1 (de) 2002-06-15
AU2078595A (en) 1995-10-23
PT752870E (pt) 2002-09-30
ES2177638T3 (es) 2002-12-16
FI963866A (fi) 1996-09-27
KR100392582B1 (ko) 2003-10-30
GB9406301D0 (en) 1994-05-25
EP0752870A1 (fr) 1997-01-15
AP9600861A0 (en) 1996-10-31
MX9604401A (es) 1997-12-31
FI963866A0 (fi) 1996-09-27
AU699081B2 (en) 1998-11-19
HU9602661D0 (en) 1996-11-28
DE69526935T2 (de) 2002-09-19
CZ280196A3 (en) 1997-02-12
DE69526935D1 (de) 2002-07-11
HUT75835A (en) 1997-05-28
JPH09511737A (ja) 1997-11-25
JP4135190B2 (ja) 2008-08-20
CA2186851A1 (fr) 1995-10-12
CN1121874C (zh) 2003-09-24
RU2139728C1 (ru) 1999-10-20
CN1150388A (zh) 1997-05-21
NZ282863A (en) 2001-06-29
FI111223B (fi) 2003-06-30
KR970702057A (ko) 1997-05-13
ZA952644B (en) 1996-01-11
WO1995026742A1 (fr) 1995-10-12
HU220858B1 (en) 2002-06-29
DK0752870T3 (da) 2002-07-15
EP0752870B1 (fr) 2002-06-05
CA2186851C (fr) 2008-11-18
NO964075D0 (no) 1996-09-27
BR9507338A (pt) 1997-09-16

Similar Documents

Publication Publication Date Title
NO964075L (no) Immunoterapeutisk middel samt anvendelse derav
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0941056T3 (da) Sphingomyelinasepræparater samt anvendelse deraf
DE19580279T1 (de) Schlüsselanhänger- und Befestigung
DE69523866T2 (de) Schleifkörper
FI944624A0 (fi) 4-aryyliaminobentsopyraani- ja niiden kaltaisia yhdisteitä
FI940870A0 (fi) Puhdistusmenetelmä ja -laite
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69417838T2 (de) Rasiergerät
BR9610109A (pt) Fecho e uso mesmo
DK0643922T3 (da) Aromatiserende middel
FI964267A0 (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
KR960014357U (ko) 인명구조 기구
ID17395A (id) Aluminosilikat berbentuk beraturan dan penggunaannya
ITMI941026A1 (it) Azaciclo e azabiciclo ammidi
KR950016466U (ko) 인쇄물 배포대
KR950030687U (ko) 좌우 겸용으로 사용할 수 있는 경첩
FI944398A0 (fi) T-staengare i foenster
ATA74494A (de) Kreis- und dosensenker
ITMI931648A1 (it) Azaciclo e azabiciclo ammidi
SE9302709D0 (sv) New use
SE9304032D0 (sv) New use
SE9302796D0 (sv) New use
SE9402421D0 (sv) New use
IT234857Y1 (it) Scudo antisfondamento e/o antiproiettile

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application